Search results
Results from the WOW.Com Content Network
This is a shortened version of the third chapter of the ICD-9: Endocrine, Nutritional and Metabolic Diseases, and Immunity Disorders. It covers ICD codes 240 to 279 . The full chapter can be found on pages 145 to 165 of Volume 1, which contains all (sub)categories of the ICD-9.
The International Classification of Diseases for Oncology (ICD-O) is a domain-specific extension of the International Statistical Classification of Diseases and Related Health Problems for tumor diseases. This classification is widely used by cancer registries. It is currently in its third revision (ICD-O-3). ICD-10 includes a list of ...
Electrolyte imbalance, or water-electrolyte imbalance, is an abnormality in the concentration of electrolytes in the body. Electrolytes play a vital role in maintaining homeostasis in the body. They help to regulate heart and neurological function, fluid balance , oxygen delivery , acid–base balance and much more.
ICD-10 coding number Diseases Database coding number Medical Subject Headings plasma cell leukemia: C90.1: D007952 Plasma cell leukemia (PCL), a lymphoproliferative disorder, [79] is a rare cancer involving a subtype of white blood cells called plasma cells. [80] Acute erythraemia and erythroleukaemia: Acute erythremic myelosis: Acute erythroid ...
Tumor lysis syndrome (TLS) is a group of metabolic abnormalities that can occur as a complication from the treatment of cancer, where large amounts of tumor cells are killed off from the treatment, releasing their contents into the bloodstream. [1]
Metabolic acidosis is a serious electrolyte disorder characterized by an imbalance in the body's acid-base balance.Metabolic acidosis has three main root causes: increased acid production, loss of bicarbonate, and a reduced ability of the kidneys to excrete excess acids. [5]
Light chain MGUS is defined as a disorder in which a serum κ to λ free light chain ratio falls outside the normal range of 0.26–1.65 (mean =0.9) provided that it is not associated with: a) any of the CRAB criteria, b) a bone marrow plasma cell count of 10 or a higher percentage of nucleated cells, c) evidence of amyloid deposition (see ...
V78 Special screening for disorders of blood and blood-forming organs; V79 Special screening for mental disorders and developmental handicaps; V80 Special screening for neurological eye and ear diseases; V81 Special screening for cardiovascular respiratory and genitourinary diseases; V82 Special screening for other conditions; v83–v84 Genetics